Comparison Chart Compass Therapeutics, Inc.
Stocks
CMPX
US20454B1044
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-10-14 EDT
|
5-day change | 1st Jan Change | ||
| 0.8790 USD | +2.57% |
|
-13.82% | -83.63% |
| 09-23 | Compass Therapeutics Shares Drop After Downgrade From Wedbush | MT |
| 09-23 | Wedbush Downgrades Compass Therapeutics to Neutral From Outperform, Cuts Price Target to $1 From $5 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| COMPASS THERAPEUTICS, INC. | Bio Therapeutic Drugs | +2.57% | -13.82% | -83.63% | -79.75% | -72.27% | 154M |  | | |
- Stock Market
- Stocks
- CMPX Stock
- Charts Compass Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
